Cotsiranib

Cotsiranib
Trade Name
Orphan Indication Primary sclerosing cholangitis
USA Market Approval USA
USA Designation Date 2017-06-15 00:00:00
Sponsor Sirnaomics, Inc.;401 Professional Drive, Suite 280;Gaithersburg, Maryland, 20879